Live stream colonoscopy
UCI Health live stream
March 30, 2016
Colorectal cancer is the second leading cause of cancer death in the U.S. It is also one of the most avoidable types of cancer.
Among the various screening tests for colorectal cancer, colonoscopy is considered the “gold standard” because it not only finds early stage cancers, but it finds and removes precancerous polyps, stopping cancer before it begins.
Why live stream a colonoscopy?
To raise awareness about the importance of colonoscopies in detecting and preventing colorectal cancer and demystify the procedure, two of our leading colorectal disease experts — Dr. Kenneth Chang and Dr. Gregory Albers — participate in a live colonoscopy.
Chang performs the colonoscopy on Albers, who is due for his regularly scheduled colorectal cancer screening. Men and women should be screened every 10 years starting at age 50 — those at higher risk should be screened earlier and more often.
Our gastroenterologists are among the most experienced at performing colonoscopies safely and painlessly. With this live stream event, Chang and Albers hope to take the fear out of colonoscopies and show that the procedure is relatively simple and performed on an out-patient basis.
Chang and Albers also answer questions about colonoscopy and colon health during the procedure. Find the Twitter chat at #UCIHealthChat.
This event was streamed on March 30 at 8 a.m. PST.
About the doctors
Dr. Kenneth Chang is a board-certified UCI Health internist and gastroenterologist who specializes in interventional endoscopy for esophageal and gastrointestinal disorders.
He is an expert in endoscopic ultrasound (EUS), EUS-guided fine needle aspiration, EUS-guided intervention and endoscopic retrograde cholangiopancreatography. He is also skilled in the endoscopic treatment of gastroesophageal reflux disease, endoscopic mucosal resection, laser-induced endomicroscopy, optical coherence tomography, radiofrequency and cryoablation therapy for Barrett’s esophagus and esophageal cancer.
Dr. Gregory Albers is a board-certified gastroenterologist whose clinical interests include capsule endoscopy, colon cancer screening, gastroesophageal reflux, inflammatory bowel disease, gut microbiome interactions and irritable bowel syndrome.
He is participating in a number of clinical trials focused on cancer chemoprevention, inflammatory bowel disease and fecal microbial transplant.